• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The 2022 ITAC evidence-based clinical practice guidelines: New update from the International Initiative on Thrombosis and Cancer to improve the care in patients with cancer-associated thrombosis.

作者信息

Frere C, Farge D, Douketis J, Connors J M

机构信息

Inserm UMRS 1166, GRC 27 GRECO, DMU BioGeM, AP-HP, Sorbonne université, Paris, France.

Internal Medicine Unit (UF 04): CRMR MATHEC, Maladies Auto-immunes et Thérapie Cellulaire, Saint-Louis Hospital, AP-HP, Nord-université de Paris, Paris, France; Université de Paris, Institut Universitaire d'Hématologie, EA 3518, Paris, France; Department of Medicine, Research Institute of the McGill University Health Centre, McGill University, Montreal PQ, Canada.

出版信息

J Med Vasc. 2022 Jul-Aug;47(3):113-115. doi: 10.1016/j.jdmv.2022.08.002.

DOI:10.1016/j.jdmv.2022.08.002
PMID:36055679
Abstract
摘要

相似文献

1
The 2022 ITAC evidence-based clinical practice guidelines: New update from the International Initiative on Thrombosis and Cancer to improve the care in patients with cancer-associated thrombosis.《2022年ITAC循证临床实践指南：血栓形成与癌症国际倡议的新更新，以改善癌症相关血栓患者的护理》
J Med Vasc. 2022 Jul-Aug;47(3):113-115. doi: 10.1016/j.jdmv.2022.08.002.
2
[New international guidelines for curative treatment and prophylaxis for venous thromboembolism (VTE) in cancer patients and the dedicated smartphone application].[癌症患者静脉血栓栓塞（VTE）的根治性治疗和预防新国际指南及专用智能手机应用程序]
J Med Vasc. 2017 Dec;42(6):375-383. doi: 10.1016/j.jdmv.2017.09.006. Epub 2017 Nov 15.
3
Cancer-associated thrombosis.癌症相关性血栓形成。
Hematol Oncol Clin North Am. 2010 Aug;24(4):695-707, viii. doi: 10.1016/j.hoc.2010.05.004.
4
Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC).直接口服抗凝剂时代癌症相关血栓形成的管理：2019年ITAC-CME临床实践指南全面综述。代表法语国家血栓与癌症研究小组（GFTC）。
J Med Vasc. 2020 Feb;45(1):28-40. doi: 10.1016/j.jdmv.2019.12.004. Epub 2020 Jan 8.
5
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer.国际临床实践指南，包括癌症患者静脉血栓栓塞症治疗和预防中直接口服抗凝剂的指南。
Lancet Oncol. 2016 Oct;17(10):e452-e466. doi: 10.1016/S1470-2045(16)30369-2.
6
[Care pathway for patients with cancer-associated thrombosis: proposals for multidisciplinary clinical practice, under the aegis of INNOVTE (Investigation Network On Venous ThromboEmbolism) network].[癌症相关性血栓形成患者的护理路径：在INNOVTE（静脉血栓栓塞症调查网络）网络支持下的多学科临床实践建议]
Rev Med Interne. 2024 Apr;45(4):183-185. doi: 10.1016/j.revmed.2024.03.009. Epub 2024 Mar 28.
7
Primary prevention of cancer-related thrombosis: special focus on ambulatory patients.
Int J Cardiol. 2014 May 15;173(3):583-4. doi: 10.1016/j.ijcard.2014.03.109. Epub 2014 Mar 20.
8
Cancer - Associated Thrombosis - A Study of Cases.癌症相关血栓形成病例研究。
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2021 Oct 26;42(2):89-97. doi: 10.2478/prilozi-2021-0025.
9
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.2019 年国际癌症患者静脉血栓栓塞症治疗和预防临床实践指南。
Lancet Oncol. 2019 Oct;20(10):e566-e581. doi: 10.1016/S1470-2045(19)30336-5. Epub 2019 Sep 3.
10
Rethinking the approach to thrombosis in patients with cancer.重新思考癌症患者血栓形成的治疗方法。
Vasc Med. 2020 Jun;25(3):208-209. doi: 10.1177/1358863X19886354. Epub 2019 Nov 13.

引用本文的文献

1
pharmacokinetic interactions of ribociclib with rivaroxaban and apixaban in rats: implications for increased drug exposure and dose adjustments.瑞博西尼与利伐沙班和阿哌沙班在大鼠体内的药代动力学相互作用：对药物暴露增加和剂量调整的影响
Front Pharmacol. 2025 Mar 31;16:1530806. doi: 10.3389/fphar.2025.1530806. eCollection 2025.
2
Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis.阿哌沙班与达肝素治疗癌症相关性静脉血栓栓塞症的疗效和安全性：系统评价和荟萃分析。
Medicina (Kaunas). 2023 Oct 20;59(10):1867. doi: 10.3390/medicina59101867.